My article in BUSINESS INSIDER published 11 February 2017.
I make an effort to stay abreast of the latest developments in science, especially where biological research combines with information technology. Some ideas in particular prove to be quite an intellectual adventure.
One field which has drawn my attention for quite a while now is synthetic biology. To this day I remember newspaper headlines a dozen plus years ago announcing the successful cloning of Dolly the Sheep. Those euphoric and promising statements intertwined with pure hysteria: “We have crossed a red line. We are well on our way to cloning humans!”, claimed some ethicists and journalists.
As we know, no human has been cloned yet, and I don’t think one will be. (Although there is no telling what goes on in the secret laboratories of the most powerful armies).
